Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

ROUTE TRAIL: DKCRUSH vs. DKRUSH Culotte in Non-Left Main Bifurcation Lesions

Coronary bifurcation lesions represent a frequent technical challenge, making between 15% and 20% of cases. Though provisional stenting is mostly used, complex bifurcations are preferably treated with two-stent strategies, such as Double-Kissing Crush (DKCR) and Double-Kissing Culotte (DKCU). Even though both strategies are supported by the current guidelines, further direct comparative studies are needed in this specific context. 

The ROUTE (Revascularization of Nonleft Main Bifurcation Through Double Kissing Crush or Double Kissing Culotte) observational, prospective study compared DKCR and DKCU clinical outcomes of in non-left main coronary bifurcation lesions. In total, it included 202 patients: 101 treated with DKCR and 101 with DKCU.

Primary end point was target lesion failure (TLF), defined as the composite of target lesion revascularization (TLR), acute target vessel MI (TVMI) and cardiac death assessed at 12-month follow-up.  

Patient and Procedure Characteristics 

Both groups presented similar baseline characteristics: mean age 64, mostly men, 72% hypertensive, 39% diabetic, 69% had dyslipidemia, 20% had a history of PCI, and 18% a history of acute MI. The cause of PCI was more frequent in stable coronary syndromes (54%), with 55% mean ejection fraction. 

Read also: TENDERA: Comparing Conventional vs. Distal Transradial Occlusion for Coronary Interventions.

As regards bifurcations, there were no significant differences in classification: the most frequent was 1.1.1 (60%), followed by 0.1.1 and, in lower proportion, 1.0.1. Neither were there differences in diameter or main and secondary vessels, or obstruction degree. 

99% of procedures were femoral. There were no differences in the use of pre and post dilation, POT technique, or stent diameter and length in main and secondary vessels. After procedure, all patients received dual antiaggregation therapy with no differences in the drugs components. 

Read also: Asymptomatic Aortic Stenosis: A Complex Decision.

Primary end point resulted in favor of DKCU, with a minor difference in TLF (3% vs. 10.8%, P = 0.028). Better outcomes were also observed in TLR (3% vs. 9.9%, P = 0.045). However, there were no significant differences in TVMI (2% vs. 3%, P = 0.651), cardiac death (0% vs. 1%, P = 0.315) or stent thrombosis.

Conclusion

In this analysis, DK Culotte was associated with a lower incidence of TLF at one-year vs DK Crush in non-left main coronary bifurcations.

Original Title: Clinical Outcomes of Double-Kissing Crush or Double-Kissing Culotte in Nonleft Main Bifurcation Lesions: The ROUTE Trial.

Reference: Serkan Kahraman et al. CirculationCirc Cardiovasc Interv. 2024;17:e014616. DOI: 10.1161/CIRCINTERVENTIONS.124.014616.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Carlos Fava
Dr. Carlos Fava
Member of the Editorial Board of solaci.org

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...